Gowling WLG advised Swedish pharmaceutical company Immedica Pharma AB on the deal.Immedica signed a licence and supply agreement with Actinium Pharmaceuticals, Inc to commercialise Iomab-B, an Antibody…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
